Biopharmaceutical digs 10 trillion market! "13th five year plan" national strategic emerging industry development plan issued

Source: pharmaceutical economic daily on December 20, 2016, the State Council issued the national strategic emerging industry development plan for the 13th five year plan (hereinafter referred to as the plan) On December 19, the document was posted on the website of the Chinese government Among them, the content related to the pharmaceutical industry mainly focuses on biotechnology According to the plan, by 2020, the scale of the biological industry will reach 8 trillion-10 trillion yuan, forming a group of new biotechnology enterprises and bioeconomy clusters with strong international competitiveness In the field of medicine, taking the rapid development of gene technology as an opportunity to promote the development of medical treatment to precision and personalized medical treatment After sorting out, the contents related to the field of medicine in the plan mainly include the following aspects: it expands the application of "Internet +" in the field of life and public service We will accelerate the innovation of industrial management systems and promote the wisdom of services such as medical care, education, social security, employment, transportation and tourism Promote the application of artificial intelligence technology in various fields Pilot demonstration will be carried out in manufacturing, education, environmental protection, transportation, commerce, health care, network security, social governance and other important fields to promote the large-scale application of artificial intelligence We will develop diversified, personalized and customized intelligent hardware and intelligent systems, focusing on the R & D and industrial development of smart homes, smart cars, smart agriculture, smart security, smart health, smart robots, and smart wearable devices Intelligent manufacturing in petrochemical, steel, non-ferrous metals, building materials, textiles, food, medicine and other process manufacturing fields, carry out integrated innovation and application demonstration of intelligent factories, and improve the intelligent level of enterprises in resource allocation, process optimization, process control, industrial chain management, quality control and traceability, energy conservation and emission reduction and safety production Biotechnology promotes the leapfrog upgrading of biomedical industry We will accelerate the R & D and application of technologies such as gene sequencing, large-scale cell culture, targeted and long-term drug release, green and intelligent production, and support the high-end development of the industry We will develop new antibodies, vaccines, gene therapy, cell therapy and other biological products and preparations, promote the innovation of chemical drugs and the development of high-end preparations, accelerate the research and development of characteristic innovative Chinese medicine, and realize the original innovation of major disease prevention and treatment drugs Support the large-scale development of biological similar drugs, carry out the research and development and production of large varieties of drugs with expired patents, accelerate the upgrading of pharmaceutical equipment, improve the level of pharmaceutical automation, digitalization and intelligence, further promote the standardization development of traditional Chinese medicine products, promote the industrial standard system to be in line with international standards, and accelerate the pace of internationalization We will develop marine innovative drugs, develop modern marine traditional Chinese medicine products with national characteristics, promote the industrialization of reagent raw materials and intermediates, and form a number of marine biomedical industry clusters Innovate the way of biomedical regulation We will establish a more scientific and efficient way of drug review and approval, accelerate the pilot of drug listing license holder system, speed up the evaluation of quality and efficacy consistency of generic drugs, and explore the pilot of new medical technology clinical experimental research accreditation system We will improve the mechanism for drug procurement and comprehensively promote the reform of the system and mechanism in the fields of drug prices and industry supervision Develop intelligent mobile new medical equipment Develop intelligent medical equipment and its software and supporting reagents, all-round telemedicine service platform and terminal equipment, develop mobile medical services, formulate relevant data standards, promote interconnection, and initially establish a modern intelligent medical service system with deep integration of information technology and biotechnology Develop high-performance medical equipment and core components We will develop high-quality medical imaging equipment, advanced radiotherapy equipment, high-throughput low-cost gene sequencer, gene editing equipment, rehabilitation medical devices and other medical equipment, and significantly improve the stability and reliability of medical equipment Using new technologies such as additive manufacturing to accelerate the innovation and industrialization of tissue and organ repair and replacement materials and implant intervention medical devices Accelerate the development of in vitro diagnostic instruments, equipment, reagents and other new products, promote the development of high-specific molecular diagnosis, biochip and other new technologies, and support rapid and accurate in vitro diagnosis and screening of tumors, genetic diseases and rare diseases Establish a biological process system with ecological safety, green and low carbon, and cyclic development We will develop high-efficiency industrial biocatalytic transformation technology system and improve the application level of green biotechnology In order to realize the green and large-scale production of pharmaceutical and chemical intermediates, the biocatalytic synthesis routes of steroids, chiral compounds and rare sugars and alcohols were established We will promote the application of green biotechnology in agriculture, chemical industry, food, medicine, textile, metallurgy, energy and other fields, and significantly reduce material consumption, energy consumption and pollutant emissions Enhance the professional service ability of biotechnology to consumers We will develop specialized diagnosis and treatment institutions, and foster new-type technical diagnosis and treatment services such as liquid biopsy and gene diagnosis that meet the standards We will develop health management services such as health examination, consultation and mobile medical services, promote the construction of a sharing platform for biological big data and medical health big data, pilot the establishment of residents' health image files, encourage the construction of an online and offline intelligent diagnosis and treatment ecosystem, and promote the professional development of medical inspection, image diagnosis and other services Improve the support level of biotechnology services to the industry We will develop pharmaceutical R & D and production services that meet international standards, and encourage pharmaceutical enterprises to strengthen cooperation with contractual R & D and commissioned manufacturing enterprises We will promote the application and transformation of new technologies such as gene detection and diagnosis in various fields, and support bioinformatics service agencies to improve their technical level Provide testing, evaluation, certification and other public services for biological products such as drugs, medical devices, seed industry, bioenergy, etc., accelerate the product listing progress and improve product quality Strategic industries build a new medical model based on stem cells and regeneration technology Speed up the research and development of body cell reprogramming science and technology, and develop new technologies for functional cell acquisition Improve the production technology platform and base of cells, tissues and organs in vitro and in vivo We will standardize the laws, regulations and standard system in the field of stem cell and regeneration, improve the mechanism of intellectual property evaluation and transformation, and continue to deepen the clinical application of stem cell and regeneration technology Development of tumor immunotherapy technology Promote the research and application of gene editing technology Establish a gene editing technology system with independent intellectual property rights, and develop new gene therapy technologies for major genetic diseases, infectious diseases, malignant tumors, etc Establish relevant animal resource platform, clinical research and transformation application base, and promote the clinical transformation and industrialization development based on gene editing research Policy support to promote the reform of streamlining administration and delegating power, combining decentralization and management, and optimizing service In the fields of telecommunications, new drugs and medical devices, and new energy vehicles production access, we will further improve the examination and approval methods, minimize prior access restrictions, revise and abolish administrative regulations and normative documents that hinder development, and stimulate the vitality of market players Adhere to the combination of management and management, distinguish different situations, actively explore and innovate regulatory methods suitable for the development of new technologies, new products, new formats and new models, not only stimulate innovation and creativity, but also prevent possible risks "Internet +", sharing economy and other new business forms that are suitable for the development prospect and potential risks, and tailor the supervision mode; strengthen the monitoring and analysis of the uncertain areas, encourage inclusive development, and avoid over strict management; strengthen the supervision of the potential risks that may cause serious adverse social consequences; Those who practice illegal operation in the name of innovation shall be resolutely banned We will strictly implement policies and measures to reduce the cost of real economic enterprises, implement policies and measures related to the fund management of scientific research projects of the central government, and promote the reform of the property rights system for scientific and technological achievements Create a fair competitive market environment We will improve the supporting rules of the anti-monopoly law, further strengthen the enforcement of anti-monopoly and anti unfair competition laws, and seriously investigate and punish the illegal activities of enterprises in the fields of information services and medical services Establish and improve the working mechanism, ensure the orderly implementation of the fair competition review system, break the regional blockade and industrial monopoly in the fields of renewable energy power generation, medical equipment, drug bidding, and increase the investigation and punishment of local protection and industrial monopoly It is also worth mentioning that the part of "promoting the development of strategic emerging industries and building a new pattern of coordinated development" in the planning puts forward to promote the key development of biomedicine in Shandong Peninsula Urban Agglomeration and the vigorous development of biomedicine and medical devices and other industries in Northeast China ■ sorting out Chen Xuewei